Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Iron-sulfur cluster assembly proteins are a diverse group of proteins essential for the maturation of iron-sulfur (Fe-S) clusters, ubiquitous prosthetic groups required for fundamental cell processes including electron transport, gene regulation, catalysis, iron metabolism, and DNA repair[6][1][7]. The assembly pathway involves cysteine desulfurases that liberate sulfur from cysteine, scaffold proteins (such as ISCU) that serve as platforms for cluster assembly, and carrier proteins/chaperones that facilitate transfer to target apoproteins[2][3][9]. Dysfunction in any part of the assembly process can result in diseases such as Friedreich’s ataxia or severe metabolic disorders[4][1]. These proteins are critical for cell viability and not considered direct therapeutic or drug targets, but serve crucial roles in cell biology and pathology[10][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Iron-sulfur cluster assembly protein (ISCU (major scaffold protein); other gene/protein names include ISCU, ISCA, NFS1, SufA, etc.).